Experts involved in its development are confident the agent has the potential to overcome shortcomings associated with conventional oral agents currently on the market.
Extravascular ICDs were developed to avoid complications such as vascular injuries, lead fractures and lead infections. Although rare, these issues can cause serious, life-threatening complications for patients.
The CGuard Prime carotid stent system from InspireMD was approved by the FDA in 2025. These data confirm the device's ability to reduce a patient's stroke risk during treatment.
Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates.
Two separate groups have published new research comparing early AVR with clinical surveillance for the treatment of asymptomatic severe aortic stenosis. Overall, the two groups found, early treatment was associated with multiple benefits—and no added risk of harm.
Researchers involved in its development are hopeful that the scanner could eventually lead to improved outcomes in cancer patients who require surgery to remove malignant tissue.
The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses machine learning to review medical images that have been collected over a prolonged period.
These animals are virtually indestructible and have long outlived the dinosaurs due to their ability to withstand extreme cold, heat, natural disasters and even cosmic radiation.
The algorithm has an edge over standard black box-style artificial intelligence applications because providers are able to see how it reaches conclusions.
It can be difficult to deliver targeted therapy to the brain due to its protective barrier, which only allows certain nutrients and oxygen to pass through.
